Miravant Medical Technologies Inc.
MRVT · OTC
12/31/2004 | 12/31/2003 | 12/31/2002 | 12/31/2001 | |
|---|---|---|---|---|
| Market Cap | $33 | $32 | $19 | $179 |
| - Cash | $3 | $1 | $1 | $1 |
| + Debt | $8 | $7 | $12 | $27 |
| Enterprise Value | $38 | $38 | $30 | $204 |
| Revenue | $0 | $0 | $0 | $5 |
| % Growth | – | -100% | -89.3% | – |
| Gross Profit | $0 | $0 | $0 | $4 |
| % Margin | – | – | 4% | 80.1% |
| EBITDA | -$13 | -$22 | -$14 | -$14 |
| % Margin | – | – | -2,716% | -296.6% |
| Net Income | -$16 | -$7 | -$16 | -$16 |
| % Margin | – | – | -3,198.4% | -350.2% |
| EPS Diluted | -0.48 | -0.3 | -0.78 | -0.88 |
| % Growth | -60% | 61.5% | 11.4% | – |
| Operating Cash Flow | -$12 | -$11 | -$9 | -$15 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$12 | -$11 | -$9 | -$16 |